Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis

Hepatology Research

Volumn 38, Issue 11, 2008, Pages 1069-1075

  Michitaka, Kojiro ^a   Tokumoto, Yoshio ^a   Uesugi, Kazuhiro ^a   Kisaka, Yoshiyasu ^a   Hirooka, Masashi ^a   Konishi, Ichiro ^a   Mashiba, Toshie ^a   Abe, Masanori ^a   Hiasa, Yoichi ^a   Matsuura, Bunzo ^a   Horiike, Norio ^a,b   Shoda, Takaaki ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Chronic hepatitis; Hepatic encephalopathy; Liver cirrhosis; Neuropsychiatric test

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DYSFUNCTION; BRAIN FUNCTION; CHRONIC HEPATITIS; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOPATHY;

EID: 53349160455     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00374.x     Document Type: Article

References (48)

1. Blei AT, Cordoba J. Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol 2001; 96: 1968-76.
2. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT, the Member of the Working Party. Hepatic encephalopathy -definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
3. Ong JP, Aggarwal A, Krieger D et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 2003; 114: 188-93.
4. Rose C, Butterworth RF, Zayed J et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117: 640-04.
5. Giewekemeyer K, Berding G, Ahl B, Ennen JC, Weissenborn K. Bradykinesia in cirrhotic patients with early hepatic encephalopathy is related to a decreased glucose uptake of frontomesial cortical areas relevant for movement initiation. J Hepatol 2007; 46: 1034-9.
6. Amodio P, Del Piccolo F, Marchetti P et al. Clinical features and survival of cirrhotic patients with subclinical cognitive alternations detected by the number connection test and computer psychometric tests. Hepatology 1999; 29: 1662-7.
7. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-73.
8. Sherlock S, Summerskill WH, White LP, Phear EA. Portal-systemic encephalopathy; neurological complications of liver disease. Lancet 1954; 4: 454-7.
9. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: Detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978; 75: 462-9.
10. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 1986; 3: 75-82.
11. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-23.
12. Sood GK, Sarin SK, Mahaptra J, Broor SL. Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: Search for a rational approach. Am J Gastroenterol 1989; 84: 156-9.
13. Weissenborn K, Heidenreich S, Giewekemeyer K, Ruckert N, Hecker H. Memory function in early hepatic encephalopathy. J Hepatol 2003; 39: 320-5.
14. Quero JC, Hartmann IJ, Meulstee J, Hop WC, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996; 24: 556-60.
15. Montagnese S, Jackson C, Morgan MY. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. J Hepatol 2007; 46: 447-58.
16. Saxena N, Bhatia M, Joshi YK, Garg PK, Dwivedi SN, Tandon RK. Electrophysiological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 2002; 22: 190-7.
17. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35: 357-66.
18. Romero-Gomez M, Cordoba J, Jover R et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007; 45: 879-85.
19. Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007; 47: 67-73.
20. Bernthal P, Hays A, Tarter RE, Thiel DV, Lecky J, Hegedus A. Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance. Hepatology 1987; 7: 107-14.
21. Geissler A, Lock G, Frund R et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997; 25: 48-54.
22. Laubenberger J, Haussinger D, Bayer S, Gufler H, Hennig J, Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997; 112: 1610-16.
23. Kale RA, Gupta RK, Saraswat VA et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006; 43: 698-706.
24. Weissenborn K, Ahl B, Fischer-Wasels D et al. Correlations between MRS alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 2007; 56: 1736-42.
25. Groeneweg M, Quero JC, Bruijn ID et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-9.
26. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004; 39: 739-45.
27. Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: A vehicle for accidents and traffic violations. Am J Gastroenterol 2007; 102: 1903-9.
28. Li YY, Nie YQ, Sha WH et al. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol 2004; 10: 2397-401.
29. Kato A, Kato M, Ishii H et al. Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria -multicenter collaborative study in Japanese. Hepatol Res 2004; 30: 71-8.
30. Karaivazoglou K, Assimakopoulos K, Thomopoulos K et al. Neuropsychological function in Greek patients with chronic hepatitis C. Liver Int 2007; 27: 798-805.
31. Citro V, Milan G, Tripodi FS et al. Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: The role of HCV infection. J Gastroenterol 2007; 42: 79-82.
32. Cordoba J, Flavia M, Jacas C et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003; 39: 231-8.
33. Fontana RJ, Bieliauskas LA, Back-Madruga C et al. Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 2005; 43: 614-22.
34. McAndrews MP, Farcnik K, Carlen P et al. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 2005; 41: 801-8.
35. Weissenborn K, Krause J, Bokemeyer M et al. Hepatitis C virus infection affects the brain -evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004; 41: 845-51.
36. Kramer L, Bauer E, Funk G et al. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002; 37: 349-54.
37. Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002; 35: 440-6.
38. Forton DM, Thomas HC, Murphy CA et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35: 433-9.
39. Desmet VJ, Gerber M, Hoofnagle JH et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
40. Dahaba AA, Worm HC, Zhu SM et al. Sensitivity and specificity of bispectral index for classification of overt hepatic encephalopathy. A multicentre, observer-blinded, validation study. Gut 2008; 57: 77-83.
41. Kircheis G, Fleig WE, Gortelmeyer R, Grafe S, Haussinger D. Assessment of low-grade hepatic encephalopathy: A critical analysis. J Hepatol 2007; 47: 642-50.
42. Watanabe A, Sakai T, Sato S et al. Clinical efficacy of lactulose in patients with and without subclinical hepatic encephalopathy. Hepatology 1997; 26: 1410-14.
43. Morgan MY, Alonso M, Stanger LC. Lactitol and lacturose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. J Hepatol 1989; 8: 208-17.
44. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-59.
45. Kircheis G, Nilius R, Held C et al. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study. Hepatology 1997; 25: 1351-60.
46. Nakaya Y, Okita K, Suzuki K et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007; 23: 113-20.
47. Muto Y, Sato S, Watanabe A et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 705-13.
48. Fabbri A, Magrini N, Bianchi G, Zoli M, Marchesini G. Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy. JPEN J Parenter Enteral Nutr 1996; 20: 159-64.